PRTA Q2 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$167,000-40.1% YoY

Gross Profit

-$9M-5638.3% margin

Operating Income

-$18M-11076.0% margin

Net Income

-$16M-9467.1% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-10.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$462M

Total Liabilities

$159M

Stockholders' Equity

$303M

Cash & Equivalents

$398M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$167,000	$279,000	-40.1%
Gross Profit	-$9M	-$31M	+69.8%
Operating Income	-$18M	-$63M	+70.7%
Net Income	-$16M	-$60M	+73.6%